Matthijs D. Kruizinga

628 total citations
27 papers, 417 citations indexed

About

Matthijs D. Kruizinga is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Physiology. According to data from OpenAlex, Matthijs D. Kruizinga has authored 27 papers receiving a total of 417 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 7 papers in Epidemiology and 6 papers in Physiology. Recurrent topics in Matthijs D. Kruizinga's work include Antibiotics Pharmacokinetics and Efficacy (4 papers), Asthma and respiratory diseases (4 papers) and Cystic Fibrosis Research Advances (3 papers). Matthijs D. Kruizinga is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (4 papers), Asthma and respiratory diseases (4 papers) and Cystic Fibrosis Research Advances (3 papers). Matthijs D. Kruizinga collaborates with scholars based in Netherlands, Australia and Denmark. Matthijs D. Kruizinga's co-authors include Adam F. Cohen, Frederik E. Stuurman, Gertjan J. Driessen, Mirjam van Veen, Jolita Bekhof, Jantien W. Wieringa, Gerdien A. Tramper‐Stranders, Nienke J. Vet, Jeroen G. Noordzij and Marlies van Houten and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Pharmacological Reviews.

In The Last Decade

Matthijs D. Kruizinga

27 papers receiving 412 citations

Peers

Matthijs D. Kruizinga

PRM

ONCOL

EPIDE

PHYSI

Steven Douedi United States

Tyler J. Albert United States

Louis Voigt United States

Stephanie D. Chao United States

Kaewjai Thepsuthammarat Thailand

Jon Torgny Wilcke Denmark

Alice Gallo de Moraes United States

Melissa Lingohr-Smith United States

Noriko Kojimahara Japan

Sanjeev Bhoi India

Steven Douedi United States

Matthijs D. Kruizinga

69 ×0.6

PRM

37 ×0.5

ONCOL

34 ×0.5

EPIDE

29 ×0.4

PHYSI

37 ×0.7

Citations per year, relative to Matthijs D. Kruizinga Matthijs D. Kruizinga (= 1×) peers Steven Douedi

Countries citing papers authored by Matthijs D. Kruizinga

Since Specialization

Citations

This map shows the geographic impact of Matthijs D. Kruizinga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthijs D. Kruizinga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthijs D. Kruizinga more than expected).

Fields of papers citing papers by Matthijs D. Kruizinga

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthijs D. Kruizinga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthijs D. Kruizinga. The network helps show where Matthijs D. Kruizinga may publish in the future.

Co-authorship network of co-authors of Matthijs D. Kruizinga

This figure shows the co-authorship network connecting the top 25 collaborators of Matthijs D. Kruizinga. A scholar is included among the top collaborators of Matthijs D. Kruizinga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthijs D. Kruizinga. Matthijs D. Kruizinga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kruizinga, Matthijs D., Hao Dang, Frederik E. Stuurman, et al.. (2025). Physical recovery after local resection of nonpedunculated rectal adenomas and T1 carcinomas: endoscopic submucosal dissection versus transanal minimally invasive surgery. Gastrointestinal Endoscopy. 102(4). 583–592.e6. 1 indexed citations

Sluijs, Pleuntje J. van der, Matthijs D. Kruizinga, Agnies M. van Eeghen, et al.. (2024). Clonazepam repurposing in ARID1B patients through conventional RCT and N-of-1 trials: an experimental strategy for orphan disease development. Journal of Medical Genetics. 62(3). 210–218. 1 indexed citations

Veen, Mirjam van, et al.. (2023). Optimization of β-Lactam Dosing Regimens in Neonatal Infections: Continuous and Extended Administration versus Intermittent Administration. Clinical Pharmacokinetics. 62(5). 715–724. 6 indexed citations

Veen, Mirjam van, Marlies A. van Houten, Jantien W. Wieringa, et al.. (2023). Adverse effect of lockdowns during the COVID-19 pandemic: increased incidence of pediatric crisis admissions due to eating disorders and adolescent intoxications. European Journal of Pediatrics. 182(3). 1137–1142. 11 indexed citations

Wieringa, Jantien W., Matthijs D. Kruizinga, Gertjan J. Driessen, C. Janneke van der Woude, & Mette Julsgaard. (2023). Validation of the Pharmacokinetic Model for Anti-TNFα Clearance in Infants Exposed to Anti-TNFα During Pregnancy. Journal of Crohn s and Colitis. 18(4). 506–515. 2 indexed citations

Kruizinga, Matthijs D., Jeroen G. Noordzij, Marlies A. van Houten, et al.. (2023). Effect of lockdowns on the epidemiology of pediatric respiratory disease—A retrospective analysis of the 2021 summer epidemic. Pediatric Pulmonology. 58(4). 1229–1236. 7 indexed citations

Kaay, Daniëlle C M van der, et al.. (2022). Objective Home-Monitoring of Physical Activity, Cardiovascular Parameters, and Sleep in Pediatric Obesity. SHILAP Revista de lepidopterología. 6(1). 19–30. 3 indexed citations

Kruizinga, Matthijs D., Menno R. Bénard, Barbara Snoeker, et al.. (2022). Mitochondrial function, grip strength, and activity are related to recovery of mobility after a total knee arthroplasty. Clinical and Translational Science. 16(2). 224–235. 1 indexed citations

Kruizinga, Matthijs D., et al.. (2021). Towards remote monitoring in pediatric care and clinical trials—Tolerability, repeatability and reference values of candidate digital endpoints derived from physical activity, heart rate and sleep in healthy children. PLoS ONE. 16(1). e0244877–e0244877. 18 indexed citations

10.

Kruizinga, Matthijs D., Mirjam van Veen, Marlies van Houten, et al.. (2021). The impact of lockdown on pediatric ED visits and hospital admissions during the COVID19 pandemic: a multicenter analysis and review of the literature. European Journal of Pediatrics. 180(7). 2271–2279. 131 indexed citations

11.

Kruizinga, Matthijs D., et al.. (2021). Postdischarge Recovery after Acute Pediatric Lung Disease Can Be Quantified with Digital Biomarkers. Respiration. 100(10). 979–988. 7 indexed citations

12.

Kruizinga, Matthijs D., et al.. (2021). Development and Technical Validation of a Smartphone-Based Cry Detection Algorithm. Frontiers in Pediatrics. 9. 651356–651356. 9 indexed citations

13.

Kruizinga, Matthijs D., Arwen Sprij, Robert J. Doll, et al.. (2021). Development and technical validation of a smartphone‐based pediatric cough detection algorithm. Pediatric Pulmonology. 57(3). 761–767. 15 indexed citations

14.

Kruizinga, Matthijs D., et al.. (2021). Population pharmacokinetics of clonazepam in saliva and plasma: Steps towards noninvasive pharmacokinetic studies in vulnerable populations. British Journal of Clinical Pharmacology. 88(5). 2236–2245. 7 indexed citations

15.

Kruizinga, Matthijs D., Frederik E. Stuurman, Vasileios Exadaktylos, et al.. (2020). Development of Novel, Value-Based, Digital Endpoints for Clinical Trials: A Structured Approach Toward Fit-for-Purpose Validation. Pharmacological Reviews. 72(4). 899–909. 34 indexed citations

16.

Kruizinga, Matthijs D., Rob Zuiker, Marieke L. de Kam, et al.. (2020). Finding Suitable Clinical Endpoints for a Potential Treatment of a Rare Genetic Disease: the Case of ARID1B. Neurotherapeutics. 17(3). 1300–1310. 10 indexed citations

17.

Kruizinga, Matthijs D., Frederik E. Stuurman, Geert Jan Groeneveld, & Adam F. Cohen. (2019). The Future of Clinical Trial Design: The Transition from Hard Endpoints to Value-Based Endpoints. Handbook of experimental pharmacology. 260. 371–397. 16 indexed citations

18.

Kruizinga, Matthijs D., Dorine Bresters, Frans J. Smiers, Arjan C. Lankester, & Robbert G. M. Bredius. (2017). The use of intravenous pentamidine for the prophylaxis of Pneumocystis pneumonia in pediatric patients. Pediatric Blood & Cancer. 64(8). 6 indexed citations

19.

Kruizinga, Matthijs D., Maarten J. D. van Tol, Vincent Bekker, et al.. (2017). Risk Factors, Treatment, and Immune Dysregulation in Autoimmune Cytopenia after Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Patients. Biology of Blood and Marrow Transplantation. 24(4). 772–778. 48 indexed citations

20.

Kruizinga, Matthijs D., et al.. (2005). Pharmacokinetics and tolerability of a novel long acting glucagon-like-peptide-1 analog CJC-1131. Clinical Pharmacology & Therapeutics. 77(2). P56–P56. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact